Zobrazeno 1 - 10
of 100
pro vyhledávání: '"N. Largeron"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Journal of Public Health. 32
Issue/problem Vaccines are an important public health intervention protecting the population against infectious diseases. The value of vaccines is broad ranging from individual to societal as achieving community immunity protects the unvaccinated, mi
Autor:
P van Dorst, J Van der Schans, C de Waure, N Largeron, C Roberts, E Beck, MJ Postma, C Boersma
Publikováno v:
Value in Health. 25:S306
Autor:
S Brassel, E Oliver, N Henderson, P O'Neill, FO Saeed, I Gibbons, R Allen, R Hudson, K Malottki, H Wentzel, N Largeron, M Garau
Publikováno v:
Value in Health. 25:S266
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Value in Health
Context: A considerable amount of evidence exists on the epidemiological features as well as on the mortality trends associated with the COVID-19 pandemic However, much less is known about the health-economics burden Objectives: To summarize the curr
Publikováno v:
PharmacoEconomics Italian Research Articles. 11:1-13
The economic burden of rotavirus gastroenteritis (RVGE) to society is high as shown from results of recent European studies. The evidence suggests that the implementation of antirotavirus vaccination programs can substantially decrease costs, thus fr
Autor:
S. Drago, M. Felice, C. Manni, A. De Marchi, Carlo Giaquinto, A. Scamarcia, M. Trichard, N. Largeron, Luigi Cantarutti, L. Da Dalt, M. P. Sidran, M. Bernuzzi, G. Giancola, M. Perin, P. Falconi, Barbara Andreola, F. Pisetta, Silvia Callegaro, R. D'Elia, C. Lista
Publikováno v:
PharmacoEconomics Italian Research Articles. 9:103-111
Background Rotavirus gastroenteritis (RVGE) has a major impact in terms of morbidity in Italy. Comprehensive data on the economic impact are needed in order to evaluate the cost-effectiveness of a Rotavirus (RV) vaccination program.
Publikováno v:
Value in Health. 16(7)
Publikováno v:
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. 15(7)
Acute paediatric rotavirus gastroenteritis (RVGE) is the leading cause of paediatric gastroenteritis worldwide. The objective of the study was to assess the average cost of a RVGE episode in children between 0 and 5 years in France.An epidemiological